You are here:

Escitalopram (Cipralex®)

Advice

Recommended for use within NHS Scotland

REASONS FOR ADVICE

Escitalopram has been shown to be as effective as citalopram in short-term use and the health economic model submitted suggests that it is also cost-effective. However, the resource usage assumptions and clinical evidence underpinning the model are not robust and no clear benefits are demonstrated over the parent product - citalopram or other effective and cheaper agents.

Drug Details

Drug Name: Escitalopram (Cipralex®)
SMC Drug ID: 17/02
Manufacturer: Lundbeck Ltd
Indication: Major depressive episodes
BNF Category:
Sub Category: 4.3 Antidepressant drugs
Submission Type: Resubmission
Status: Accepted
Date Advice Published: 7 March 2003

Archived Advice

Full submission 8 November 2002

Back